This site is intended for healthcare professionals
News

Sanofi’s avalglucosidase alfa shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease.

Read time: 2 mins
Last updated:17th Jun 2020
Published:17th Jun 2020
Condition: Pompe Disease
Type: drug
Register free for full access to medthority.com